These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8822482)

  • 21. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration.
    Cerruti C; Pilotte NS; Uhl G; Kuhar MJ
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):132-8. PubMed ID: 8015373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.
    Parsons LH; Koob GF; Weiss F
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1182-91. PubMed ID: 7562486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels.
    Flores G; Wood GK; Barbeau D; Quirion R; Srivastava LK
    Brain Res; 1998 Dec; 814(1-2):34-40. PubMed ID: 9838033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC; Kalivas PW
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cocaine self-administration in rats differentially alters mRNA levels of the monoamine transporters and striatal neuropeptides.
    Arroyo M; Baker WA; Everitt BJ
    Brain Res Mol Brain Res; 2000 Nov; 83(1-2):107-20. PubMed ID: 11072100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents.
    Pradhan AA; Cumming P; Clarke PB
    Brain Res; 2002 Nov; 954(2):227-36. PubMed ID: 12414106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats.
    Louis M; Clarke PB
    Neuropharmacology; 1998 Dec; 37(12):1503-13. PubMed ID: 9886673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
    Bowers MB; Malison RT; Seibyl JP; Kosten TR
    Biol Psychiatry; 1998 Feb; 43(4):278-81. PubMed ID: 9513737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of NMDA receptor subunits and nitric oxide synthase expression during cocaine withdrawal.
    Loftis JM; Janowsky A
    J Neurochem; 2000 Nov; 75(5):2040-50. PubMed ID: 11032893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi.
    Yeghiayan SK; Andersen SL; Baldessarini RJ
    Neurosci Lett; 1997 Nov; 236(3):147-50. PubMed ID: 9406758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.
    Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A
    Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal development of the dopamine transporter: a quantitative autoradiographic study.
    Coulter CL; Happe HK; Murrin LC
    Brain Res Dev Brain Res; 1996 Apr; 92(2):172-81. PubMed ID: 8738124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical changes in cocaine withdrawal.
    Kuhar MJ; Pilotte NS
    Trends Pharmacol Sci; 1996 Jul; 17(7):260-4. PubMed ID: 8756185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal.
    Xia Y; Goebel DJ; Kapatos G; Bannon MJ
    J Neurochem; 1992 Sep; 59(3):1179-82. PubMed ID: 1494906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain.
    Sharpe LG; Pilotte NS; Shippenberg TS; Goodman CB; London ED
    Synapse; 2000 Sep; 37(4):292-7. PubMed ID: 10891866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.
    Piras AP; Zhou Y; Schlussman SD; Ho A; Kreek MJ
    Neuroscience; 2010 Aug; 169(2):751-7. PubMed ID: 20452406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine.
    Matell MS; King GR
    Psychopharmacology (Berl); 1997 Apr; 130(3):242-8. PubMed ID: 9151358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats.
    Tang W; Wesley M; Freeman WM; Liang B; Hemby SE
    J Neurochem; 2004 May; 89(4):1021-33. PubMed ID: 15140200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine.
    Kozell LB; Meshul CK
    Synapse; 2004 Mar; 51(4):224-32. PubMed ID: 14696010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.